ConductScience.org, home

Paper20179192

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.

Jin D and 8 others. Cancer Res, 2010. Cited by 365 papers, by iCite.

Cite this record

ConductScience Library. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Papers, record 20179192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20179192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
PubMed
Journal
Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
365
iCite
Relative citation ratio, by iCite
7.73
iCite
Revised in PubMed
2025-05-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin DDachuan
2Fan JJie
3Wang LLong
4Thompson LFLinda F
5Liu AAijie
6Daniel BJBenjamin J
7Shin TTahiro
8Curiel TJTyler J
9Zhang BBin

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
5'-NucleotidaseMajor topic
Ovarian NeoplasmsMajor topic
T-LymphocytesMajor topic
Adenosine
Adenosine A2 Receptor Antagonists
Animals
Apoptosis
Female
Flow Cytometry
Immunotherapy, Adoptive
Mice
Mice, Inbred C57BL
Mice, Knockout
Pyrimidines
RNA, Small Interfering
Receptor, Adenosine A2A
Triazoles

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI018220NIAID NIH HHSUnited StatesR01AI018220PubMed and NIHNIH RePORTER
R01 CA149669NCI NIH HHSUnited StatesR01CA149669PubMed and NIHNIH RePORTER
UL1 RR025767NCRR NIH HHSUnited StatesUL1RR025767PubMed and NIHNIH RePORTER
UL1 TR000149NCATS NIH HHSUnited StatesUL1TR000149PubMed and NIHNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19553767Ecto-enzyme and signaling functions of lymphocyte CD73.Immunol Rev1998https://conductscience.org/library/papers/9553767PubMed
214550503A glance at adenosine receptors: novel target for antitumor therapy.Pharmacol Ther2003https://conductscience.org/library/papers/14550503PubMed
315776005Immunosuppressive networks in the tumour environment and their therapeutic relevance.Nat Rev Cancer2005https://conductscience.org/library/papers/15776005PubMed
418404426From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.Purinergic Signal2007https://conductscience.org/library/papers/18404426PubMed
516718268Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.Melanoma Res2006https://conductscience.org/library/papers/16718268PubMed
69325320Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.J Biol Chem1997https://conductscience.org/library/papers/9325320PubMed
71690738Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage.J Biol Chem1990https://conductscience.org/library/papers/1690738PubMed
818311159Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.Br J Pharmacol2008https://conductscience.org/library/papers/18311159PubMed
918404475Physiological roles for ecto-5'-nucleotidase (CD73).Purinergic Signal2006https://conductscience.org/library/papers/18404475PubMed
109169488Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia.J Clin Invest1997https://conductscience.org/library/papers/9169488PubMed
119113412T cell signalling through CD73.Cell Signal1997https://conductscience.org/library/papers/9113412PubMed
1218591671CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18591671PubMed
139808167CD73 expression and fyn-dependent signaling on murine lymphocytes.Eur J Immunol1998https://conductscience.org/library/papers/9808167PubMed
1418292929Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).Int J Oncol2008https://conductscience.org/library/papers/18292929PubMed
1516920910Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.J Immunol2006https://conductscience.org/library/papers/16920910PubMed
1618404431CD39 and control of cellular immune responses.Purinergic Signal2007https://conductscience.org/library/papers/18404431PubMed
177595232CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.J Exp Med1995https://conductscience.org/library/papers/7595232PubMed
1817449799Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.Blood2007https://conductscience.org/library/papers/17449799PubMed
1911171087Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice.Biochem J2001https://conductscience.org/library/papers/11171087PubMed
20315423Ecto-5'-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia.J Immunol1979https://conductscience.org/library/papers/315423PubMed

See all 49 referencesDownload CSV of references

Cited by247

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 365 citations.

PMIDTitleJournalYearIn PapersSource
42763389Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design.Mol Cancer2026https://conductscience.org/library/papers/42763389PubMed
42611560CD73 inhibition overcomes adaptive immune resistance to PARP inhibition in models of prostate cancer.J Clin Invest2026https://conductscience.org/library/papers/42611560PubMed
42577400CD73 is associated with glycolysis related metabolic programs and CD8+ T cell suppression in pancreatic ductal adenocarcinoma.Front Immunol2026https://conductscience.org/library/papers/42577400PubMed
42094596Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.Theranostics2026https://conductscience.org/library/papers/42094596PubMed
42064235Purinergic signaling modulates endothelial-to-mesenchymal transition in human aortic valve endothelial cells.BBA Adv2026https://conductscience.org/library/papers/42064235PubMed
41909123Targeting ubiquitin-specific peptidase 22 in solid tumours: from ubiquitination to immunotherapy.Front Cell Dev Biol2026https://conductscience.org/library/papers/41909123PubMed
41631877A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma.Cancer Discov2026https://conductscience.org/library/papers/41631877PubMed
41613810PIK3R1 as a Gastric Cancer Biomarker Linked to CD73 + Treg-Mediated Immunosuppression.Oncol Res2026https://conductscience.org/library/papers/41613810PubMed
41573544Enzymatic and microenvironmental regulation in adenosine metabolism-mediated immunosuppression.Front Immunol2025https://conductscience.org/library/papers/41573544PubMed
41276526Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors.Nat Commun2025https://conductscience.org/library/papers/41276526PubMed
41022728HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques.Nat Commun2025https://conductscience.org/library/papers/41022728PubMed
40916400Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy.Korean J Clin Oncol2025https://conductscience.org/library/papers/40916400PubMed
40715608Applications of nanoparticles in CAR-T cell therapy: non-viral manufacturing, enhancing in vivo function, and in vivo generation of CAR-T cells.Med Oncol2025https://conductscience.org/library/papers/40715608PubMed
40610421Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.Nat Commun2025https://conductscience.org/library/papers/40610421PubMed
40534663Insights from Clinical Trials on A2A Adenosine Receptor Antagonists for Cancer Treatment.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534663PubMed
40530308Therapeutic potential of adenosine receptor modulators in cancer treatment.RSC Adv2025https://conductscience.org/library/papers/40530308PubMed
40429961A Comprehensive Review of Long Non-Coding RNAs in the Cancer-Immunity Cycle: Mechanisms and Therapeutic Implications.Int J Mol Sci2025https://conductscience.org/library/papers/40429961PubMed
40420185Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40420185PubMed
40390144The progress and prospects of targeting the adenosine pathway in cancer immunotherapy.Biomark Res2025https://conductscience.org/library/papers/40390144PubMed
40385579CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients.Front Med (Lausanne)2025https://conductscience.org/library/papers/40385579PubMed

See all 247 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
ENTPD1953PubTator's text mininghttps://conductscience.org/library/genes/953NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
NT5E4907PubTator's text mininghttps://conductscience.org/library/genes/4907NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20179192

GET https://conductscience.org/api/papers/v1/20179192/references?page=2